Skip to content
Immunity Project logo

Immunity Project

Immunity Project is a YC Winter 2014 (W14) company. Based in San Francisco, CA, USA. Team of 11.

  • Health Tech
  • Biotech

About Immunity Project

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Immunity Project develops a free HIV vaccine modeled on the biology of HIV controllers, people whose immune systems naturally suppress the virus. The vaccine is designed to replicate that immune response in recipients, replacing the absence of any widely accessible HIV prevention or cure. Immunity Project operates as a nonprofit and plans to distribute the vaccine at no cost upon successful clinical validation.

Business model

Free distribution; nonprofit model with no charge to recipients

From the Y Combinator listing

How Immunity Project describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

The free HIV vaccine.

We're developing a free vaccine to cure HIV and AIDs. Immunity Project is a non-profit initiative dedicated to developing an HIV vaccine. We hacked the HIV life cycle to develop a vaccine that gives you the same power as HIV controllers. With success in our clinical trials, our goal is to give our vaccine away to the world for free.

Facts

Industry
Unspecified / Unspecified
Location
San Francisco, CA, USA
Team size
11
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works